Skip to content
Life Sciences Series C Founded 2011

Health Gene Technologies

Health Gene Technologies develops molecular diagnostic solutions for disease detection and prevention. The company creates reagent kits and testing platforms for clinical applications including infectious disease detection, genetic testing, and other diagnostic categories. Founded in 2011, headquartered in Ningbo, China, The company has raised $48.2M at the Series C stage, backed by investors including Shenzhen…

📍 Ningbo, China · Genomics,

Funding snapshot

Last roundSeries C
Amount$15M
Date8 August 2022
Total raised$48M
Team size30

About

Health Gene Technologies develops molecular diagnostic solutions for disease detection and prevention. The company creates reagent kits and testing platforms for clinical applications including infectious disease detection, genetic testing, and other diagnostic categories. Founded in 2011, headquartered in Ningbo, China, The company has raised $48.2M at the Series C stage, backed by investors including Shenzhen Capital Group, Boyuan Capital, Anfeng Venture Capital, Qiming Venture Partners, Gl-investment. The company operates in the Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools sector. with business models spanning Genomics > Enabling Technologies > Instrument Systems, Life Sciences Platforms and Tools > Research Services > Genomics. serving markets in China. Provider of DNA testing solutions for diagnostic solutions..

Business model

Genomics > Enabling Technologies > Instrument Systems,

Life Sciences Platforms and Tools > Research Services > Genomics

Institutional investors

Shenzhen Capital Group Boyuan Capital Anfeng Venture Capital Qiming Venture Partners Gl-investment BioTrack Capital Blue Lake Capital Prosperico Venture

Latest coverage

No articles yet.

Raising like Health Gene Technologies?

Analyze your pitch deck before your next raise.

Analyze My Deck →